Skip to main content

Day: February 26, 2021

Diamondback Energy, Inc. Announces Closing of Acquisition from Guidon Operating LLC

MIDLAND, Tx., Feb. 26, 2021 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced that it has completed its previously announced acquisition of leasehold interests and related oil and gas assets from Guidon Operating LLC, a portfolio company of Blackstone Energy Partners. Aggregate consideration consisted of $375 million in cash and 10.68 million shares of the Company’s common stock after accounting for post-effective date adjustments. As a result of the acquisition, Diamondback adds approximately 32,500 net acres in the Northern Midland Basin, primarily held by production allowing for capital efficient full field development.About Diamondback Energy, Inc.Diamondback is an independent oil and natural gas company headquartered in Midland, Texas focused on the acquisition, development,...

Continue reading

Titan Mining Updates Reporting at Mineral Ridge

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI) (“Titan” or the “Company”) announces that in satisfying the reporting requirements of the British Columbia Securities Commission Titan commissioned an independent consultant to prepare a technical report on the Mineral Ridge Project.The technical report for Titan was based on a technical report with an effective date of January 2, 2018, summarizing a feasibility study that was prepared for Scorpio Gold Corporation (“Scorpio Gold”) on Mineral Ridge. The technical report prepared for Titan differs in some respects to that prepared for Scorpio Gold given the more recent effective date of the report of December 1, 2020, and includes the reclassification of the Measured Mineral Resources within the existing heap leach pad to Indicated Mineral...

Continue reading

Dividend Distribution Proposal  

Maranello (Italy), February 26, 2021 – Ferrari N.V. (NYSE/MTA: RACE) (the “Company”) announced today that its Board of Directors intends to recommend to the Company’s shareholders a dividend distribution to the holders of common shares of Euro 0.867 per common share, corresponding to a total distribution of approximately Euro 160 million.The distribution will be subject to its approval by the Annual General Meeting of Shareholders which is scheduled to be held on April 15, 2021.If shareholders approve the proposed dividend distribution, the ex-date is expected to be April 19, 2021, the record date April 20, 2021 on both MTA and NYSE and the payment date May 5, 2021.AttachmentFNV 2021 Dividend Distribution Proposal PR ENG

Continue reading

Orphazyme announces participation in upcoming virtual investor conferences

Orphazyme A/SInvestor news                                                                                                       No. 04/2021                                                                                                           Company Registration No. 32266355Copenhagen, Denmark and Chicago, IL, February 26, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Company”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative rare diseases, today announced that Anders Vadsholt, interim CEO and CFO of Orphazyme, will be participating in the following upcoming investor conferences:Cowen Healthcare Conference, March 1-3, 2021:Panel discussion moderated by Cowen analysts Phil Nadeau, Ritu Baral and Boris Peaker entitled “New Drug Launches Panel” on Wednesday, March...

Continue reading

KludeIn I Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 1, 2021

NEW YORK, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) — KludeIn I Acquisition Corp. (NASDAQ: INKAU) (the “Company”) announced that, commencing March 1, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock (“Class A Common Stock”) and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Class A common stock and warrants that are separated will trade on the NASDAQ Capital Market under the symbols “INKA” and “INKAW,” respectively. Those units not separated will continue to trade on the NASDAQ Capital Market under the symbol “INKAU.”A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on...

Continue reading

Madison Pacific Properties Inc. (TSX: MPC and MPC.C) announces results of Annual General Meeting

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company), reports the voting results of the Annual General Meeting of its shareholders held February 25, 2021 in Vancouver, British Columbia.The following six nominees were re-elected as directors of the Company by the following votes:In addition, PricewaterhouseCoopers LLP was re-appointed as the auditor for the Company.About the Company: Madison Pacific Properties Inc. is a Vancouver-based real estate company with approximately $608 million in investment and development properties, including the Company’s proportionate share of properties held through jointly-controlled partnerships. The Company’s investment portfolio comprises 52 properties with approximately 1.83 million rentable sq. ft. of industrial and commercial space and a 50%...

Continue reading

Landmark Infrastructure Partners LP Announces 2020 K-1 Tax Package Availability

EL SEGUNDO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) today announced that it has completed the 2020 tax packages for unitholders of the Common Units (LMRK), Series A Preferred Units (LMRKP), Series B Preferred Units (LMRKO) and Series C Preferred Units (LMRKN), including the Schedule K-1. The tax packages are currently available online and may be accessed at www.taxpackagesupport.com/landmark or on LMRK’s website at www.landmarkmlp.com under “Investors/K-1 Tax Information”. The Partnership will begin printing and mailing the 2020 tax packages to all unitholders on March 1, 2021. For additional information or assistance, unitholders may contact Tax Package Support toll free at (844) 275-9872 (8 a.m. – 5 p.m. CT; Monday – Friday).About Landmark Infrastructure...

Continue reading

GLOBAL TECH INDUSTRIES GROUP, INC. RETIRES GENEVA ROTH REMARK HOLDINGS, INC. CONVERTIBLE DEBT.

New York, New York, Feb. 26, 2021 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “Company”), www.gtii-us.com a development stage company, focused on acquiring new and innovative technologies in diverse industries, after quotation on the OTCQB marketplace, and retaining International Monetary for capital formation and support of its investor relations efforts, today announced that it has retired its convertible debt.GTII’s President, Kathy Griffin, stated, ”GTII takes great pleasure in announcing the full repayment of the convertible debt facility previously entered into last November, 2020. Our Board and our project team are working tirelessly to execute the company’s business plan. The company was accepted back onto the “QB” as of January, 2021, so this is a continuation of what we believe will be...

Continue reading

Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion

CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will host a Town Hall at 1 P.M., Eastern Time on Thursday, March 18, 2021.Information for shareholders interested in attending will be available at the Company’s Investors section of the website: https://ir.adialpharma.com/About Adial Pharmaceuticals, Inc.Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated...

Continue reading

DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update

BROSSARD, Quebec, Feb. 26, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the exercise of 5,076,922 stock warrants within the past five months. The cash position of the Corporation as of today is $1,433,000.In the coming weeks, the Corporation expects to submit a first claim for disbursement under a financing agreement in the form of an interest-free loan of up to $2,000,000 from the government of Québec to support global commercialization. The financing agreement was initially announced on September 8th, 2020.The Corporation is also announcing a grant of 1,200,000 stock options to one of its directors. Stock options vest at 50% per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.